QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Womens health models
Talk about team spirit! Quantify’s Oskar Frisell, Mathias Lilja, Rosa Lauppe, Fredrik Borgström, Lena Jacobs and Kirk Geale teamed up to develop a cost-effectiveness model for the treatment of uterine fibroids in women of reproductive age in England that was presented at the ESG 2021 conference. To assess the clinical efficacy of treatment a generalised symptom-based […]
Puneet Kaushik joins Quantify to lead Evidence Review & Synthesis team and APAC expansion
Quantify is excited to welcome Country Director Puneet Kaushik to the growing Quantify Research team to lead our new Evidence Review and Synthesis team and the expansion into the Asia-Pacific region. Puneet has more than 10 years’ OF HEOR experience, having occupied leadership roles both in consultancies and in the pharmaceutical industry.
“Building a business unit around evidence review and synthesis is an important milestone for Quantify Research”, says […]
Quantify Research launches Evidence Review and Synthesis business unit together with its expansion to the Asia-Pacific market
STOCKHOLM, Sweden, 11 November 2021 – Today, Quantify Research (QUANTIFY) announced the creation of a new business unit dedicated to Evidence Review and Synthesis as part of its expansion into India and the Asia-Pacific (APAC) market to expand the breadth and depth of their business and service offerings. QUANTIFY is a global partner to the life science industry in the development of real-world evidence generation, data science, health […]
Stina Kettunen joins Quantify!
On Monday we welcomed Stina Kettunen who will strengthen our team as a Project Leader within Market Access. Before joining Quantify, Stina worked as a Health Economics Expert in her home country, Finland. Being the adventurous type, she chose to pack her bags and move to Sweden last Friday to join our Stockholm team. Stinas versatile experience with the market access activities in the Finnish setting, will support Quantify in gaining […]